How have clinical trials changed in chronic lymphocytic leukemia?

John Gribben, MD, DSc, FRCPath, FMed Sci from Bart's Cancer Institute, London, UK discusses how chronic lymphocytic leukemia (CLL) clinical trials have changed over time. Today, trials involve treatments that are known to be beneficial to patients and novel agents tend to be trialed in combination to improve patient response whilst not increasing toxicity. Recorded at the 2016 American Society of Hematology (ASH) Annual Meeting, held in San Diego, CA.

Видео How have clinical trials changed in chronic lymphocytic leukemia? канала Patient Power Europe